OUH - Ischemic heart disease

Ischemic Heart Disease

Academic interests

Prevention of reperfusion injury in myocardial infarction
Troponin - both molecular and clinical aspects
"FIRE"-trial: Chair of study in patients with myocardial infarction
EU-FP7, MITOCARE: Head of clinical trial consortium to study patients with myocardial infarction
Atrial fibrillation - pharmacotherapy

Information from Dan Atar's personal page at UiO

Recent publications

Agewall S (2019)
Antiplatelet treatment in acute coronary syndrome. Still an issue
Eur Heart J Cardiovasc Pharmacother, 5 (3), 125-126
DOI 10.1093/ehjcvp/pvz018, PubMed 31210265

Fossum S, Næss Ø, Halvorsen S, Tell GS, Vikanes ÅV (2019)
Long-term cardiovascular morbidity following hyperemesis gravidarum: A Norwegian nationwide cohort study
PLoS One, 14 (6), e0218051
DOI 10.1371/journal.pone.0218051, PubMed 31188868

von Lueder TG, Atar D, Agewall S, Jensen JK, Hopper I, Kotecha D, Mentz RJ, Kim MH, Serebruany VL (2019)
All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System
Am J Ther (in press)
DOI 10.1097/MJT.0000000000000883, PubMed 31145139

More publications